NCT03621748 is a NA clinical trial of Awake Anesthesia Protocol in Intracranial Glioma, sponsored by Mayo Clinic.

Who is sponsoring NCT03621748?

NCT03621748 is sponsored by Mayo Clinic.

What drugs are being tested in NCT03621748?

Interventions in NCT03621748: Awake Anesthesia Protocol, Non-awake Anesthesia Protocol.

What condition does NCT03621748 study?

NCT03621748 studies Intracranial Glioma.

Is NCT03621748 still recruiting?

NCT03621748 is currently completed. Last updated 26 May 2023.

Last reviewed 2023-05-26 · How we verify

NCT03621748

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Awake vs. Asleep Craniotomy for Non-eloquent Gliomas

Completed NA Last updated 26 May 2023

What this trial tests

NA trial testing Awake Anesthesia Protocol in Intracranial Glioma in 1 participant. Completed in 21 May 2023.

Timeline

1 June 2019

Primary endpoint
21 May 2023

21 May 2023

Quick facts

Lead sponsor	Mayo Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	1
Start date	1 June 2019
Primary completion	21 May 2023
Estimated completion	21 May 2023
Sites	1 location across United States

Drugs / interventions tested

Awake Anesthesia Protocol
Non-awake Anesthesia Protocol

Conditions studied

Intracranial Glioma — all drugs for Intracranial Glioma →

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Intracranial Glioma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study protocol examines a comparison between local and general anesthesia (Awake vs. Asleep Craniotomy) in the removal of brain tumors that are in areas of the brain that do not directly control bodily functions (non-eloquent gliomas).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Safe surgery for glioblastoma: Recent advances and modern challenges.
Gerritsen JKW, Broekman MLD, De Vleeschouwer S, Schucht P, et al · · 2022 · cited 59× · PMID 36127890 · DOI 10.1093/nop/npac019

Verify or expand the search:

Other recruiting trials for Intracranial Glioma

Currently open trials in the same condition.

NCT05556473 — F-Tryptophan PET/CT in Human Cancers · Phase 1 · recruiting

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03621748 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 26 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03621748.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing